Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study - Concepedia

Concepedia

Publication | Open Access

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study

DOI Full Paper Access

98

Citations

18

References

2022

Year

Claudia Angela Maria Fulgenzi, Jaekyung Cheon, Antonio D’Alessio, Naoshi Nishida, Celina Ang, Thomas U. Marron, Linda Y. Wu, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota,

European Journal of Cancer

Drug SafetyOncologyMedicineClinical TrialsTherapeutic EfficacyImmune Checkpoint InhibitorPharmacotherapyClinical PracticeAb-real StudyReproducible SafetyImmunotherapyPharmacology

References

	Year	Citations

Page 1

Page 1